• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    South America Pharmacovigilance Market

    ID: MRFR/Pharma/49097-HCR
    200 Pages
    Rahul Gotadki
    September 2025

    South America Pharmacovigilance Market Research Report By Service Type (Adverse Event Reporting, Risk Assessment, Data Mining, Pharmacovigilance Consulting), By Deployment Mode (Cloud-Based, On-Premise), By Source (Spontaneous Reporting, Literature Reports, Scheduled Reporting), By End User (Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations) and By Regional (Brazil, Mexico, Argentina, Rest of South America)- Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    South America Pharmacovigilance Market Research Report- Forecast to 2035 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Table of Contents

    South America Pharmacovigilance Market Summary

    The South America Pharmacovigilance market is projected to grow from 790 USD Million in 2024 to 1500 USD Million by 2035.

    Key Market Trends & Highlights

    South America Pharmacovigilance Key Trends and Highlights

    • The market is expected to witness a compound annual growth rate (CAGR) of 6.0 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 1500 USD Million, indicating robust growth potential.
    • In 2024, the market is valued at 790 USD Million, reflecting the current demand for pharmacovigilance services in the region.
    • Growing adoption of advanced technologies due to increasing regulatory requirements is a major market driver.

    Market Size & Forecast

    2024 Market Size 790 (USD Million)
    2035 Market Size 1500 (USD Million)
    CAGR (2025-2035) 6.0%

    Major Players

    Parexel International, Syntropy, Medpace, Syneos Health, IQVIA, Charles River Laboratories, Celerion, Wuxi AppTec, Covance, PRA Health Sciences, Pharmaceutical Product Development, Veristat, Accenture

    South America Pharmacovigilance Market Trends

    Growing regulatory requirements and increased awareness of medication safety are driving major changes in the South America Pharmacovigilance Market. By implementing stronger pharmacovigilance frameworks, regional governments are demonstrating their dedication to public health and motivating pharmaceutical corporations to improve their safety monitoring procedures. The need for thorough pharmacovigilance services is rising as regulatory agencies in nations like Brazil and Argentina are aggressively revising their policies to conform to international norms. Furthermore, this market's landscape is changing due to the emergence of cutting-edge technologies like big data analytics and artificial intelligence. 

    By combining these technologies, data can be collected and analyzed more effectively, which helps businesses better detect safety indicators and enhance patient outcomes. Additionally, there is a growing trend of regulatory agencies and pharmaceutical companies working together to share data and improve the openness of drug monitoring procedures. There are many opportunities in the South American pharmacovigilance market. Creating customized pharmacovigilance solutions that meet the particular requirements of regional healthcare systems has a lot of room to grow. 

    Additionally, a growing pool of data needs efficient management and control due to the rising prevalence of chronic diseases and the corresponding rise in pharmaceutical usage.Businesses have the chance to support their pharmacovigilance procedures by investing in infrastructure and training as healthcare systems change. The formation of partnerships between pharmaceutical corporations and regional health authorities is indicative of a more proactive approach to pharmacovigilance in South America in recent years. In addition to raising drug safety standards, this cooperative approach seeks to increase public confidence in the healthcare system. 

    The trends influencing the South American pharmacovigilance market point to a positive trend towards increased safety, adherence to regulations, and technological development.

    South America Pharmacovigilance Market Drivers

    Market Segment Insights

    Get more detailed insights about South America Pharmacovigilance Market Research Report- Forecast to 2035

    Regional Insights

    The Regional segment of the South America Pharmacovigilance Market plays a crucial role in ensuring drug safety and monitoring adverse effects across various nations. Brazil significantly influences the market due to its large population and extensive pharmaceutical industry, making it a key player in pharmacovigilance initiatives. Mexico is also important, providing a well-established regulatory framework and strong government support, which enhances safety monitoring practices. Argentina, with its growing healthcare sector, emphasizes the need for effective pharmacovigilance to safeguard public health. 

    At the same time, the Rest of South America showcases diverse market dynamics influenced by regulatory developments and healthcare challenges.Trends such as increased digitalization and adoption of advanced technologies within pharmacovigilance processes further shape the market landscape in the region. Growth drivers, including the rising demand for patient safety, regulatory compliance, and the ongoing evolution of healthcare systems, create a dynamic environment for the South America Pharmacovigilance Market. 

    Overall, understanding these individual markets is essential for addressing unique regional challenges while capitalizing on opportunities that enhance drug safety across South America.

    South America Pharmacovigilance Market Region

    Source: Primary Research, Secondary Research, Market Research Future Database, and Analyst Review

    Key Players and Competitive Insights

    The South America Pharmacovigilance Market is characterized by a landscape that is steadily evolving, influenced by stringent regulatory requirements, increasing demand for patient safety, and the growing complexity of drug development processes. As pharmaceutical companies seek to enhance their medication monitoring systems, the competitive environment is now marked by innovative solutions, strategic collaborations, and a focus on technology-driven advancements. 

    Companies operating in this market are leveraging data analytics, artificial intelligence, and real-time monitoring to enhance their pharmacovigilance capabilities, ensuring compliance with regulatory mandates while addressing the challenges posed by drug safety. This competitive domain is witnessing heightened activity as firms vie for market share, catering to the region's unique healthcare challenges and regulatory conditions, thereby creating a dynamic ecosystem for pharmacovigilance services.Within the South America Pharmacovigilance Market, Parexel International stands out as a leading player known for its robust service offerings and commitment to patient safety. 

    The company boasts a strong presence across Brazil and other key countries in the region, where it provides comprehensive pharmacovigilance solutions tailored to meet local regulatory requirements. Parexel International's strengths lie in its extensive experience in clinical development and regulatory consulting, allowing it to effectively support pharmaceutical and biotechnology companies in navigating the complexities of drug safety evaluation.

    The firm’s integration of cutting-edge technology aids in streamlining adverse event reporting and ensures efficient signal detection, thereby reinforcing its position as a trusted partner in the pharmacovigilance arena of South America.Syntropy, operating in the South America Pharmacovigilance Market, focuses on delivering innovative pharmacovigilance and risk management solutions. 

    The company is recognized for its commitment to utilizing advanced technologies to enhance data analysis and improve the quality of safety reporting. Syntropy's portfolio includes a range of services, such as post-marketing surveillance, data mining, and regulatory compliance services, which are crucial in addressing the diverse needs of pharmaceutical clients in the region. The firm has made significant strides in establishing its market presence through strategic partnerships and collaborations with local healthcare authorities and institutions. 

    Additionally, Syntropy's strengths include a dedicated focus on building robust safety databases and a commitment to continuous improvement through mergers and acquisitions that allow for the expansion of its service capabilities. This focus has enabled Syntropy to reinforce its standing in the South America pharmacovigilance landscape, ensuring that it remains competitive and responsive to the evolving demands of the market.

    Key Companies in the South America Pharmacovigilance Market market include

    Industry Developments

    The South America Pharmacovigilance Market has recently experienced various developments, particularly with the increased focus on drug safety regulations and reporting mechanisms. In recent months, companies such as Parexel International and Medpace have increased their regional presence, enhancing their service offerings to local pharmaceutical firms. 

    Notably, in October 2023, Covance announced an expansion of its operations in Brazil to better align with local compliance regulations. Additionally, IQVIA reported a rise in demand for pharmacovigilance services fueled by the increasing number of clinical trials in the region. In terms of mergers and acquisitions, Syneos Health successfully acquired a smaller local company in September 2023 to bolster its pharmacovigilance capabilities in Latin America, which highlights the growing consolidation trend in this space. 

    The market valuation across these companies has shown significant growth fueled by heightened regulatory scrutiny and a surge in drug development activities. Over the last couple of years, the increase in investment in research and development by firms like Pharmaceutical Product Development and Celerion has further solidified the competitive landscape, driving innovations in drug safety monitoring and reporting standards critical for regional compliance.

    Market Segmentation

    Pharmacovigilance Market Source Outlook

    • Spontaneous Reporting
    • Literature Reports
    • Scheduled Reporting

    Pharmacovigilance Market End User Outlook

    • Pharmaceutical Companies
    • Biotechnology Companies
    • Contract Research Organizations

    Pharmacovigilance Market Regional Outlook

    • Brazil
    • Mexico
    • Argentina
    • Rest of South America

    Pharmacovigilance Market Service Type Outlook

    • Adverse Event Reporting
    • Risk Assessment
    • Data Mining
    • Pharmacovigilance Consulting

    Pharmacovigilance Market Deployment Mode Outlook

    • Cloud-Based
    • On-Premise

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2023 745.0(USD Million)
    MARKET SIZE 2024 790.0(USD Million)
    MARKET SIZE 2035 1500.0(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 6.002% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED Parexel International, Syntropy, Medpace, Syneos Health, IQVIA, Charles River Laboratories, Celerion, Wuxi AppTec, Covance, PRA Health Sciences, Pharmaceutical Product Development, Veristat, Accenture
    SEGMENTS COVERED Service Type, Deployment Mode, Source, End User, Regional
    KEY MARKET OPPORTUNITIES Growing regulatory compliance needs, Increasing investment in biopharma, Expansion of telemedicine services, Adoption of AI technologies, Rising demand for patient safety initiatives
    KEY MARKET DYNAMICS regulatory compliance requirements, increasing drug safety concerns, growth in biotechnology sector, rising clinical trials, technological advancements in reporting
    COUNTRIES COVERED Brazil, Mexico, Argentina, Rest of South America

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Leave a Comment

    FAQs

    What is the expected market size of the South America Pharmacovigilance Market in 2024?

    The South America Pharmacovigilance Market is expected to be valued at 790.0 USD Million in 2024.

    What is the projected market size for the South America Pharmacovigilance Market by 2035?

    By 2035, the South America Pharmacovigilance Market is projected to reach a value of 1500.0 USD Million.

    What is the expected CAGR for the South America Pharmacovigilance Market between 2025 and 2035?

    The South America Pharmacovigilance Market is expected to grow at a CAGR of 6.002% from 2025 to 2035.

    Which country is expected to dominate the South America Pharmacovigilance Market?

    Brazil is expected to dominate the market, with a projected value of 600.0 USD Million by 2035.

    What is the market size of the South America Pharmacovigilance Market in Argentina for 2024?

    Argentina's Pharmacovigilance Market is valued at 150.0 USD Million in 2024.

    Which service type in the South America Pharmacovigilance Market has the highest projected value in 2035?

    Adverse Event Reporting is projected to have the highest value of 430.0 USD Million by 2035.

    What is the market size for Data Mining services in the South America Pharmacovigilance Market for 2024?

    Data Mining services in the market are valued at 200.0 USD Million in 2024.

    What is the anticipated market growth rate for Mexico in the South America Pharmacovigilance Market from 2024 to 2035?

    Mexico's segment is expected to grow from 200.0 USD Million in 2024 to 400.0 USD Million by 2035.

    Who are the key players in the South America Pharmacovigilance Market?

    Prominent players include Parexel International, Syntropy, and IQVIA among others.

    What are some emerging trends in the South America Pharmacovigilance Market?

    The market is witnessing trends in increased digitalization, regulatory compliance, and innovative data analytics.

    1. EXECUTIVE
    2. SUMMARY
    3. Market Overview
    4. Key Findings
    5. Market Segmentation
    6. Competitive Landscape
    7. Challenges and Opportunities
    8. Future Outlook
    9. MARKET INTRODUCTION
    10. Definition
    11. Scope of the study
    12. Research Objective
    13. Assumption
    14. Limitations
    15. RESEARCH
    16. METHODOLOGY
    17. Overview
    18. Data
    19. Mining
    20. Secondary Research
    21. Primary
    22. Research
    23. Primary Interviews and Information Gathering
    24. Process
    25. Breakdown of Primary Respondents
    26. Forecasting
    27. Model
    28. Market Size Estimation
    29. Bottom-Up
    30. Approach
    31. Top-Down Approach
    32. Data
    33. Triangulation
    34. Validation
    35. MARKET
    36. DYNAMICS
    37. Overview
    38. Drivers
    39. Restraints
    40. Opportunities
    41. MARKET FACTOR ANALYSIS
    42. Value chain Analysis
    43. Porter's
    44. Five Forces Analysis
    45. Bargaining Power of Suppliers
    46. Bargaining
    47. Power of Buyers
    48. Threat of New Entrants
    49. Threat
    50. of Substitutes
    51. Intensity of Rivalry
    52. COVID-19
    53. Impact Analysis
    54. Market Impact Analysis
    55. Regional
    56. Impact
    57. Opportunity and Threat Analysis
    58. South
    59. America Pharmacovigilance Market, BY Service Type (USD Million)
    60. Adverse
    61. Event Reporting
    62. Risk Assessment
    63. Data
    64. Mining
    65. Pharmacovigilance Consulting
    66. South
    67. America Pharmacovigilance Market, BY Deployment Mode (USD Million)
    68. Cloud-Based
    69. On-Premise
    70. South
    71. America Pharmacovigilance Market, BY Source (USD Million)
    72. Spontaneous
    73. Reporting
    74. Literature Reports
    75. Scheduled
    76. Reporting
    77. South America Pharmacovigilance
    78. Market, BY End User (USD Million)
    79. Pharmaceutical
    80. Companies
    81. Biotechnology Companies
    82. Contract
    83. Research Organizations
    84. South
    85. America Pharmacovigilance Market, BY Regional (USD Million)
    86. Brazil
    87. Mexico
    88. Argentina
    89. Rest
    90. of South America
    91. Competitive Landscape
    92. Overview
    93. Competitive
    94. Analysis
    95. Market share Analysis
    96. Major
    97. Growth Strategy in the Pharmacovigilance Market
    98. Competitive
    99. Benchmarking
    100. Leading Players in Terms of Number of Developments
    101. in the Pharmacovigilance Market
    102. Key developments and
    103. growth strategies
    104. New Product Launch/Service Deployment
    105. Merger
    106. & Acquisitions
    107. Joint Ventures
    108. Major
    109. Players Financial Matrix
    110. Sales and Operating Income
    111. Major
    112. Players R&D Expenditure. 2023
    113. Company
    114. Profiles
    115. Parexel International
    116. Financial
    117. Overview
    118. Products Offered
    119. Key
    120. Developments
    121. SWOT Analysis
    122. Key
    123. Strategies
    124. Syntropy
    125. Financial
    126. Overview
    127. Products Offered
    128. Key
    129. Developments
    130. SWOT Analysis
    131. Key
    132. Strategies
    133. Medpace
    134. Financial
    135. Overview
    136. Products Offered
    137. Key
    138. Developments
    139. SWOT Analysis
    140. Key
    141. Strategies
    142. Syneos Health
    143. Financial
    144. Overview
    145. Products Offered
    146. Key
    147. Developments
    148. SWOT Analysis
    149. Key
    150. Strategies
    151. IQVIA
    152. Financial
    153. Overview
    154. Products Offered
    155. Key
    156. Developments
    157. SWOT Analysis
    158. Key
    159. Strategies
    160. Charles River Laboratories
    161. Financial
    162. Overview
    163. Products Offered
    164. Key
    165. Developments
    166. SWOT Analysis
    167. Key
    168. Strategies
    169. Celerion
    170. Financial
    171. Overview
    172. Products Offered
    173. Key
    174. Developments
    175. SWOT Analysis
    176. Key
    177. Strategies
    178. Wuxi AppTec
    179. Financial
    180. Overview
    181. Products Offered
    182. Key
    183. Developments
    184. SWOT Analysis
    185. Key
    186. Strategies
    187. Covance
    188. Financial
    189. Overview
    190. Products Offered
    191. Key
    192. Developments
    193. SWOT Analysis
    194. Key
    195. Strategies
    196. PRA Health Sciences
    197. Financial
    198. Overview
    199. Products Offered
    200. Key
    201. Developments
    202. SWOT Analysis
    203. Key
    204. Strategies
    205. Pharmaceutical Product Development
    206. Financial
    207. Overview
    208. Products Offered
    209. Key
    210. Developments
    211. SWOT Analysis
    212. Key
    213. Strategies
    214. Veristat
    215. Financial
    216. Overview
    217. Products Offered
    218. Key
    219. Developments
    220. SWOT Analysis
    221. Key
    222. Strategies
    223. Accenture
    224. Financial
    225. Overview
    226. Products Offered
    227. Key
    228. Developments
    229. SWOT Analysis
    230. Key
    231. Strategies
    232. References
    233. Related
    234. Reports
    235. LIST
    236. OF ASSUMPTIONS
    237. South America Pharmacovigilance Market
    238. SIZE ESTIMATES & FORECAST, BY SERVICE TYPE, 2019-2035 (USD Billions)
    239. South
    240. America Pharmacovigilance Market SIZE ESTIMATES & FORECAST, BY DEPLOYMENT MODE,
    241. 2035 (USD Billions)
    242. South America Pharmacovigilance
    243. Market SIZE ESTIMATES & FORECAST, BY SOURCE, 2019-2035 (USD Billions)
    244. South
    245. America Pharmacovigilance Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035
    246. (USD Billions)
    247. South America Pharmacovigilance Market
    248. SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)
    249. PRODUCT
    250. LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    251. ACQUISITION/PARTNERSHIP
    252. LIST
    253. Of figures
    254. MARKET SYNOPSIS
    255. SOUTH
    256. AMERICA PHARMACOVIGILANCE MARKET ANALYSIS BY SERVICE TYPE
    257. SOUTH
    258. AMERICA PHARMACOVIGILANCE MARKET ANALYSIS BY DEPLOYMENT MODE
    259. SOUTH
    260. AMERICA PHARMACOVIGILANCE MARKET ANALYSIS BY SOURCE
    261. SOUTH
    262. AMERICA PHARMACOVIGILANCE MARKET ANALYSIS BY END USER
    263. SOUTH
    264. AMERICA PHARMACOVIGILANCE MARKET ANALYSIS BY REGIONAL
    265. KEY
    266. BUYING CRITERIA OF PHARMACOVIGILANCE MARKET
    267. RESEARCH
    268. PROCESS OF MRFR
    269. DRO ANALYSIS OF PHARMACOVIGILANCE MARKET
    270. DRIVERS
    271. IMPACT ANALYSIS: PHARMACOVIGILANCE MARKET
    272. RESTRAINTS
    273. IMPACT ANALYSIS: PHARMACOVIGILANCE MARKET
    274. SUPPLY / VALUE
    275. CHAIN: PHARMACOVIGILANCE MARKET
    276. PHARMACOVIGILANCE MARKET,
    277. BY SERVICE TYPE, 2025 (% SHARE)
    278. PHARMACOVIGILANCE MARKET,
    279. BY SERVICE TYPE, 2019 TO 2035 (USD Billions)
    280. PHARMACOVIGILANCE
    281. MARKET, BY DEPLOYMENT MODE, 2025 (% SHARE)
    282. PHARMACOVIGILANCE
    283. MARKET, BY DEPLOYMENT MODE, 2019 TO 2035 (USD Billions)
    284. PHARMACOVIGILANCE
    285. MARKET, BY SOURCE, 2025 (% SHARE)
    286. PHARMACOVIGILANCE MARKET,
    287. BY SOURCE, 2019 TO 2035 (USD Billions)
    288. PHARMACOVIGILANCE
    289. MARKET, BY END USER, 2025 (% SHARE)
    290. PHARMACOVIGILANCE
    291. MARKET, BY END USER, 2019 TO 2035 (USD Billions)
    292. PHARMACOVIGILANCE
    293. MARKET, BY REGIONAL, 2025 (% SHARE)
    294. PHARMACOVIGILANCE
    295. MARKET, BY REGIONAL, 2019 TO 2035 (USD Billions)
    296. BENCHMARKING
    297. OF MAJOR COMPETITORS

    South America Pharmacovigilance Market Segmentation

     

     

     

    • Pharmacovigilance Market By Service Type (USD Million, 2019-2035)

      • Adverse Event Reporting
      • Risk Assessment
      • Data Mining
      • Pharmacovigilance Consulting

     

    • Pharmacovigilance Market By Deployment Mode (USD Million, 2019-2035)

      • Cloud-Based
      • On-Premise

     

    • Pharmacovigilance Market By Source (USD Million, 2019-2035)

      • Spontaneous Reporting
      • Literature Reports
      • Scheduled Reporting

     

    • Pharmacovigilance Market By End User (USD Million, 2019-2035)

      • Pharmaceutical Companies
      • Biotechnology Companies
      • Contract Research Organizations

     

    • Pharmacovigilance Market By Regional (USD Million, 2019-2035)

      • Brazil
      • Mexico
      • Argentina
      • Rest of South America

     

    Pharmacovigilance Market Regional Outlook (USD Million, 2019-2035)

     

     

    • South America Outlook (USD Million, 2019-2035)

      • South America Pharmacovigilance Market by Service Type

        • Adverse Event Reporting
        • Risk Assessment
        • Data Mining
        • Pharmacovigilance Consulting
      • South America Pharmacovigilance Market by Deployment Mode Type

        • Cloud-Based
        • On-Premise
      • South America Pharmacovigilance Market by Source Type

        • Spontaneous Reporting
        • Literature Reports
        • Scheduled Reporting
      • South America Pharmacovigilance Market by End User Type

        • Pharmaceutical Companies
        • Biotechnology Companies
        • Contract Research Organizations
      • South America Pharmacovigilance Market by Regional Type

        • Brazil
        • Mexico
        • Argentina
        • Rest of South America
      • BRAZIL Outlook (USD Million, 2019-2035)
      • BRAZIL Pharmacovigilance Market by Service Type

        • Adverse Event Reporting
        • Risk Assessment
        • Data Mining
        • Pharmacovigilance Consulting
      • BRAZIL Pharmacovigilance Market by Deployment Mode Type

        • Cloud-Based
        • On-Premise
      • BRAZIL Pharmacovigilance Market by Source Type

        • Spontaneous Reporting
        • Literature Reports
        • Scheduled Reporting
      • BRAZIL Pharmacovigilance Market by End User Type

        • Pharmaceutical Companies
        • Biotechnology Companies
        • Contract Research Organizations
      • MEXICO Outlook (USD Million, 2019-2035)
      • MEXICO Pharmacovigilance Market by Service Type

        • Adverse Event Reporting
        • Risk Assessment
        • Data Mining
        • Pharmacovigilance Consulting
      • MEXICO Pharmacovigilance Market by Deployment Mode Type

        • Cloud-Based
        • On-Premise
      • MEXICO Pharmacovigilance Market by Source Type

        • Spontaneous Reporting
        • Literature Reports
        • Scheduled Reporting
      • MEXICO Pharmacovigilance Market by End User Type

        • Pharmaceutical Companies
        • Biotechnology Companies
        • Contract Research Organizations
      • ARGENTINA Outlook (USD Million, 2019-2035)
      • ARGENTINA Pharmacovigilance Market by Service Type

        • Adverse Event Reporting
        • Risk Assessment
        • Data Mining
        • Pharmacovigilance Consulting
      • ARGENTINA Pharmacovigilance Market by Deployment Mode Type

        • Cloud-Based
        • On-Premise
      • ARGENTINA Pharmacovigilance Market by Source Type

        • Spontaneous Reporting
        • Literature Reports
        • Scheduled Reporting
      • ARGENTINA Pharmacovigilance Market by End User Type

        • Pharmaceutical Companies
        • Biotechnology Companies
        • Contract Research Organizations
      • REST OF SOUTH AMERICA Outlook (USD Million, 2019-2035)
      • REST OF SOUTH AMERICA Pharmacovigilance Market by Service Type

        • Adverse Event Reporting
        • Risk Assessment
        • Data Mining
        • Pharmacovigilance Consulting
      • REST OF SOUTH AMERICA Pharmacovigilance Market by Deployment Mode Type

        • Cloud-Based
        • On-Premise
      • REST OF SOUTH AMERICA Pharmacovigilance Market by Source Type

        • Spontaneous Reporting
        • Literature Reports
        • Scheduled Reporting
      • REST OF SOUTH AMERICA Pharmacovigilance Market by End User Type

        • Pharmaceutical Companies
        • Biotechnology Companies
        • Contract Research Organizations

     

     

    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials